Journal
INFLAMMATORY BOWEL DISEASES
Volume 28, Issue 10, Pages 1565-1572Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/ibd/izab313
Keywords
health confidence; health care utilization; disease outcomes; patient engagement; patient-reported outcome measures
Categories
Funding
- AbbVie
- AMAG Pharmaceuticals
- Eli Lilly
- Helmsley Charitable Trust
- Janssen Biotech, Inc.
- Luitpold Pharmaceuticals, Inc.
- Nephroceuticals LLC
- Nestle Health Sciences
- Pfizer, Inc.
- Takeda Pharmaceuticals USA, Inc.
- UCB/Ferring
Ask authors/readers for more resources
This study aimed to examine the associations between health confidence, inflammatory bowel disease (IBD) outcomes, and health care utilization among adults with IBD. The study found strong associations between health confidence and patients' well-being, symptomatic disease activity, opioid use, and glucocorticoid use. Patients with low health confidence (<8) were more likely to have frequent interactions with their healthcare provider, IBD-related emergency department visits, and hospitalizations.
Background We aimed to examine the associations between health confidence (one's belief on the degree of control on their health and disease), inflammatory bowel disease (IBD) outcomes, and health care utilization among adults with IBD. Methods In total, 17,205 surveys were analyzed from a cross-sectional sample of IBD patients at 23 gastroenterology (GI) practices participating in the Crohn's and Colitis Foundations' IBD Qorus Learning Health System. We used bivariate analyses and multivariable logistic regression to examine associations between health confidence and disease activity, opioid use, glucocorticoid use, well-being, and health care utilization. We used receiver operating curve analysis to determine a clinically relevant cutoff for health confidence (0-10 Likert scale). Results Health confidence was highly correlated with patients' well-being, symptomatic disease activity, opioid use, and glucocorticoid use (all P < .0001). Health confidence scores <8 had 69% sensitivity for emergency department (ED) visits and 66% for hospitalizations. In patients with inactive disease, patients with low health confidence (<8) were 10 times more likely to call/message the GI office >4 times/month (adjusted odds ratio [aOR], 10.3; 95% CI, 6.1-17.3; P < .0001), 3-4 times more likely to have an IBD-related ED visit (aOR, 4.0; 95% CI, 2.9, 5.4. P < .0001), or hospitalization (aOR, 3.0, 95% CI, 2.1, 4.1, P < .0001) compared with patients with high health confidence (>= 8). Conclusions In a large, national sample of adults with IBD, there were strong associations between patients' health confidence and multiple disease outcome measures. Health confidence scores <8 on a 0-10 Likert scale may be clinically useful to screen for patients who are at risk for ED visits and hospitalizations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available